China Medical System Keeps Authorised Share Capital Unchanged in February

China Medical System Holdings ( (HK:0867) ) has shared an update.

China Medical System Holdings reported no change in its authorised share capital for the month ended 28 February 2026, keeping the total at 20 billion ordinary shares with a par value of USD 0.005, equivalent to authorised capital of USD 100 million. The unchanged capital base indicates the company did not pursue new authorisations, splits, or reductions during the month, suggesting a period of capital structure stability for shareholders and potential investors.

The reporting of a steady authorised share position may signal that China Medical System is not currently engaging in major equity-driven financing or restructuring activities. For market participants, this stability in authorised capital can imply a predictable share supply environment, with no immediate signs of dilution or consolidation moves stemming from changes in the registered share capital.

More about China Medical System Holdings

China Medical System Holdings Limited is a pharmaceutical company listed on the Hong Kong Stock Exchange under stock code 00867. The group operates in the healthcare sector and issues ordinary shares with a par value of USD 0.005, reflecting a capital structure typical of mid to large-cap listed drug and medical product developers.

For a thorough assessment of 0867 stock, go to TipRanks’ Stock Analysis page.